Researchers Halt Trial of Promising Sickle Cell Treatment
By BY GINA KOLATA
Health
https://ift.tt/3pQFstW
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
New York Times
Sickle Cell Anemia, Leukemia, Bone Marrow, Genetic Engineering, Clinical Trials, DNA (Deoxyribonucleic Acid), Drugs (Pharmaceuticals)
February 22, 2021 at 11:38PM